MEG3 and chronic myelogenous leukemia, BCR-ABL1 positive: Decrease in MEG3 expression was accompanied by the progression of the disease from chronic phase to the CML in blast crisis and all of this was caused by the advanced hyper-methylation of MEG3 promoter [137].